University Hospital Leuven
KU Leuven is currently by far the largest university in Belgium in terms of research funding and expenditure (EUR 475 million in 2017) and is a charter member of LERU. KU Leuven takes up the 10th place of European HES institutions hosting ERC grants (as first legal signatories of the grant agreement). During FP7 over 500 research projects relied on their services, of which 95 coordinated by KU Leuven. Over 300 H2020 projects were approved by the European Commission so far, of which 198 collaborative actions.
Role within 3TR
- We will pool existing datasets (transcriptomics, genomics, metagenomics, serum proteomics) or patients with IBD from Leuven (retrospective part)
- We will contribute patients and samples to the prospective PRIORIZE-IBD observation study where patients will be bio-sampled before and during treatment with biologicals and/or small molecules (both early and late time point)
